CAJ | 학술논문

高脂血症性胰腺炎(HLP)发病率呈逐年增高趋势.原发性HLP常见于患者家族性脂蛋白酶缺乏和apo-CⅡ缺乏.继发性HTG的主要原因为酗酒、糖尿病、肥胖、高脂饮食及服用药物等.降脂药物、血浆置换(PE)或连续性血液滤过(CVVH)、低分子肝素、胰岛素等是HLP治疗的主要手段.患者生活方式的改变和控制诱发因素是预防的关键.本文总结了HLP的研究进展.
고지혈증성이선염(HLP)발병솔정축년증고추세.원발성HLP상견우환자가족성지단백매결핍화apo-CⅡ결핍.계발성HTG적주요원인위후주、당뇨병、비반、고지음식급복용약물등.강지약물、혈장치환(PE)혹련속성혈액려과(CVVH)、저분자간소、이도소등시HLP치료적주요수단.환자생활방식적개변화공제유발인소시예방적관건.본문총결료HLP적연구진전.
Hyperlipidemic pancreatitis (HLP) has an increasing incidence.Primary HLP is common in patients with familial difficiency of lipoprotion lipase or apo-C Ⅱ.While for secondary HLP,the common reasons are excessive drinking,diabetes,obesity,fat-rich diet and special medications.Lipidlowering drugs,plasma exchange (PE) or continuous veno-venous hemofiltration (CVVH),low molecular heparin as well as insulin,have been widely used for the treatment of HLP.Changing of diet and lifestyle,in addition to controlling risk factors are the keys to preventing HLP.This article summarizes the latest perspectives and research progress of HLP.